Collegium Pharmaceutical (COLL) Long-Term Debt Repayments: 2016-2025
Historic Long-Term Debt Repayments for Collegium Pharmaceutical (COLL) over the last 6 years, with Sep 2025 value amounting to $16.1 million.
- Collegium Pharmaceutical's Long-Term Debt Repayments was N/A to $16.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.6 million, marking a year-over-year change of. This contributed to the annual value of $107.8 million for FY2024, which is 33.65% down from last year.
- Per Collegium Pharmaceutical's latest filing, its Long-Term Debt Repayments stood at $16.1 million for Q3 2025, which was down 0.00% from $16.1 million recorded in Q2 2025.
- Collegium Pharmaceutical's Long-Term Debt Repayments' 5-year high stood at $138.6 million during Q1 2023, with a 5-year trough of $12.5 million in Q1 2021.
- For the 3-year period, Collegium Pharmaceutical's Long-Term Debt Repayments averaged around $39.8 million, with its median value being $20.0 million (2023).
- In the last 5 years, Collegium Pharmaceutical's Long-Term Debt Repayments spiked by 1,150.00% in 2021 and then plummeted by 66.94% in 2024.
- Over the past 5 years, Collegium Pharmaceutical's Long-Term Debt Repayments (Quarterly) stood at $12.5 million in 2021, then skyrocketed by 100.00% to $25.0 million in 2022, then dropped by 4.55% to $23.9 million in 2023, then crashed by 32.34% to $16.1 million in 2024, then plummeted by 64.77% to $16.1 million in 2025.
- Its last three reported values are $16.1 million in Q3 2025, $16.1 million for Q2 2025, and $16.1 million during Q1 2025.